Liang R - Search Results

1

Progress of research on molecular targeted therapies for colorectal cancer.

Huang S, Ye J, Gao X, Huang X, Huang J, Lu L, Lu C, Li Y, Luo M, Xie M, Lin Y, Liang R. Huang S, et al. Among authors: liang r. Front Pharmacol. 2023 Aug 8;14:1160949. doi: 10.3389/fphar.2023.1160949. eCollection 2023. Front Pharmacol. 2023. PMID: 37614311 Free PMC article. Review.

2

Correlation between ERCC1 expression and concurrent chemotherapy and radiotherapy in patients with locally advanced nasopharyngeal cancer.

Liang R, Lin Y, Liu ZH, Liao XL, Yuan CL, Liao SN, Li YQ. Liang R, et al. Genet Mol Res. 2015 May 29;14(2):5804-11. doi: 10.4238/2015.May.29.12. Genet Mol Res. 2015. PMID: 26125779 Free article.

3

Functional polymorphisms of the cyclooxygenase-2 gene and prognosis of hepatocellular carcinoma - a cohort study in Chinese people.

Liang R, Yan XX, Lin Y, Li Q, Yuan CL, Liu ZH, Li YQ. Liang R, et al. Genet Mol Res. 2016 May 9;15(2). doi: 10.4238/gmr.15028093. Genet Mol Res. 2016. PMID: 27173352 Free article.

4

Integrative Analysis Reveals the Potential Role and Prognostic Value of GOLM1 in Hepatocellular Carcinoma.

Lin Y, He Z, Gao X, Lu L, Lu C, Huang J, Luo M, Ye J, Liang R. Lin Y, et al. Among authors: liang r. Oxid Med Cell Longev. 2022 Sep 28;2022:8284500. doi: 10.1155/2022/8284500. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36211823 Free PMC article.

5

Prognosis-Related Molecular Subtypes and Immune Features Associated with Hepatocellular Carcinoma.

Ye J, Lin Y, Gao X, Lu L, Huang X, Huang S, Bai T, Wu G, Luo X, Li Y, Liang R. Ye J, et al. Among authors: liang r. Cancers (Basel). 2022 Nov 21;14(22):5721. doi: 10.3390/cancers14225721. Cancers (Basel). 2022. PMID: 36428813 Free PMC article.

6

The miRNA-185-5p/STIM1 Axis Regulates the Invasiveness of Nasopharyngeal Carcinoma Cell Lines by Modulating EGFR Activation-Stimulated Switch from E- to N-Cadherin.

Luo Y, Ye J, Deng Y, Huang Y, Liu X, He Q, Chen Y, Li Q, Lin Y, Liang R, Li Y, Wei J, Zhang J. Luo Y, et al. Among authors: liang r. Molecules. 2023 Jan 13;28(2):818. doi: 10.3390/molecules28020818. Molecules. 2023. PMID: 36677874 Free PMC article.

7

Advances in post-operative prognostic models for hepatocellular carcinoma.

He Z, She X, Liu Z, Gao X, Lu LU, Huang J, Lu C, Lin Y, Liang R, Ye J. He Z, et al. Among authors: liang r. J Zhejiang Univ Sci B. 2023 Mar 15;24(3):191-206. doi: 10.1631/jzus.B2200067. J Zhejiang Univ Sci B. 2023. PMID: 36915996 Free PMC article. Review.

8

STIM1-regulated exosomal EBV-LMP1 empowers endothelial cells with an aggressive phenotype by activating the Akt/ERK pathway in nasopharyngeal carcinoma.

Deng Y, Liu X, Huang Y, Ye J, He Q, Luo Y, Chen Y, Li Q, Lin Y, Liang R, Li Y, Wei J, Zhang J. Deng Y, et al. Among authors: liang r. Cell Oncol (Dordr). 2023 Aug;46(4):987-1000. doi: 10.1007/s13402-023-00790-0. Epub 2023 Mar 14. Cell Oncol (Dordr). 2023. PMID: 36917356

9

Homologous recombination repair gene mutations in colorectal cancer favors treatment of immune checkpoint inhibitors.

Lin Y, Luo S, Luo M, Lu X, Li Q, Xie M, Huang Y, Liao X, Zhang Y, Li Y, Liang R. Lin Y, et al. Among authors: liang r. Mol Carcinog. 2023 Sep;62(9):1271-1283. doi: 10.1002/mc.23562. Epub 2023 May 26. Mol Carcinog. 2023. PMID: 37232365

10

RBM38 Reverses Sorafenib Resistance in Hepatocellular Carcinoma Cells by Combining and Promoting lncRNA-GAS5.

Gao X, Lu C, Liu Z, Lin Y, Huang J, Lu L, Li S, Huang X, Tang M, Huang S, He Z, She X, Liang R, Ye J. Gao X, et al. Among authors: liang r. Cancers (Basel). 2023 May 24;15(11):2897. doi: 10.3390/cancers15112897. Cancers (Basel). 2023. PMID: 37296859 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,041 results

Search Page

Filters